期刊文献+

p53蛋白表达与三阴性乳腺癌及其预后相关性的Meta分析 被引量:2

Correlation of p53 expression with triple negative breast cancer and its prognosis:a meta analysis
下载PDF
导出
摘要 目的:系统评价p53在三阴性乳腺癌中的表达情况以及其阳性表达对三阴性乳腺癌患者的预后因素的影响。方法通过PubMed、Medline、CNKI、WanFang data、VIP数据库检索国内外已公开发表的相关文献资料。由2位研究者按照纳入与排除标准独立筛选文献、提取资料和质量评价后,采用RevMan 5.0软件进行Meta分析。结果纳入文献13篇,其中中文文献11篇,英文文献2篇。Meta分析结果显示:p53蛋白在三阴性乳腺癌患者中的表达较高,具有显著的统计学意义[ OR=2.02,95%CI(1.28,3.19)]。三阴性乳腺癌中p53阳性表达组的淋巴结转移率和复发率高于阴性组,无病生存率和总生存率低于阴性组,且结果均有统计学意义。结论 p53在三阴性乳腺癌中高表达,且具有一定的临床预后指导意义,其可以作为评估三阴性乳腺癌预后的一个独立因素,且在以后的研究中,有可能可作为指导三阴性乳腺癌靶向治疗的一个靶点。 Objective To evaluate the expression of p53 in triple negative breast cancer( TNBC) and its impact on the prognosis of TNBC systematically. Methods Documents published on PubMed, Medline,CNKI,CNKI,Wanfang data,and VIP data were screened for relative researches. Two reviewers filtered,extracted and assessed the literatures according to the inclusion criteria and exclusion criteria. The meta analysis was conducted by using RevMan5. 0 software. Result A total 13 trails were included,con-taining 11 Chinese documents and 2 English documents. The meta analysis showed that p53 is significantly expressed in TNBC[OR=2. 02,95%CI(1. 28,3. 19)]. TNBC patients with positive p53 expression had higher rates in lymph node metastasis[OR=2. 02,95%CI(1. 28,3. 19)],recurrence[OR=3. 39,95%CI(1.45,7. 90)],metastasis[OR =2. 65(1. 36,5. 18)],disease-free survival[OR =0. 29(0. 18, 0. 47)]and overall survival[OR=0. 29(0. 18,0. 47)]than patients with negative p53 expression. Con-clusion p53 is overexpressed in TNBC,which plays a certain role in guiding the clinical prognosis of TN-BC. It can be regarded as an independent factor to evaluate the prognosis of TNBC,and a therapeutic tar-get in further studies.
作者 李祥 孙圣荣
出处 《临床外科杂志》 2015年第4期293-296,共4页 Journal of Clinical Surgery
关键词 三阴性乳腺癌 P53 预后 META分析 triple negative breast cancer p53 prognosis meta analysis
  • 相关文献

参考文献17

  • 1Parkin DM, Bray F, Felay J, et al. Global cancer statistics, 2002 [ J ]. CA cancer J clin,2005,55 (2) :74-108.
  • 2Foulkes WD, Smith IE, Reis-Filho JS, et al. Triple-negative tumors [J]. N Engl J Med,2010,363(20) :1938-1948.
  • 3Carey LA,Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study E J 1. JAMA, 2006, 295 (21) :2492-2502.
  • 4Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemieal and clini- cal characterization of the basal-like subtype of invasive breast carci- noma[ J ]. Clin Cancer Res ,2004,10( 16 ) :5367-5374.
  • 5Bartek J, Iggo R, Gaannon J, et al. Genetic and immunochemicalanaly- sis of mutant P53 in human breast cancer ceil line [ J ]. Oncogene, 1990,5 (6) :893-899.
  • 6Norberg T, Klaar S, Karl" G, et al. Increased P53 mutation frequen- cyduring tumor progression-resuh from a breast cancer cohort [ J ]. Cancer Res ,2001,61 (22) :8317-8321.
  • 7Soussi T, Brroud C. A ssessin TP 53 status in human tumours to evalu- ate clinical outcome[ J ]. Nat Rev Cancer,200] , 1 (3) :233-240.
  • 8Turnrt N, Moretti E, Sielari O, et al. Targeting triple negative breast cancer:Is p53 the answer [ J ]Cancer Treatment Reviews, 2013,39 ( 5 ) :541-550.
  • 9杜华劲,张月君,周彩云.Ki-67和p53在三阴性乳腺癌中的表达和意义[J].中华全科医学,2013,11(9):1393-1395. 被引量:12
  • 10黄硕,陈健,贾谊君,王永坤,陆云姝,吴克瑾.三阴性乳腺癌中MMP9和P53的表达与其预后的关系研究[J].现代生物医学进展,2014,14(5):881-884. 被引量:7

二级参考文献58

  • 1杨扬,李曰庆.胶滴肿瘤药敏检测技术检测乳腺癌细胞对三氧化二砷和粉防己碱的敏感性[J].中华临床医师杂志(电子版),2011,5(17):5210-5212. 被引量:2
  • 2何振宇,李彪,胡英,管迅行.Ki67在乳腺癌组织中的表达及临床病理分析[J].中国初级卫生保健,2005,19(12):94-95. 被引量:16
  • 3杜长征,李惠平,马力文,付卫,王墨培,贾廷珍,赵红梅,侯宽永.中国乳腺癌患者p53表达临床生物学意义的Meta分析[J].中国癌症杂志,2005,15(6):514-517. 被引量:23
  • 4Gerdes J.Lemke H,Baisch H,et al.Cell cycle analysis of a cell proliferation associated human unclear antigen defined by the monoelonalahtibody Ki-67[J].J Immunol,1984,133(13):1710-1715.
  • 5Hall PA,Levison DA,Woods AL,et al.Proliferating cell nuclear antigen(P CNA)immunolocalization in paraffin sections:all index of cell proliferation with evidence of deregulated expression in some neoplasm[J]J Pathol,1990,162(4):258-294.
  • 6Liu M,Lawson G,Delos M,et al.Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki-67 in biopsies of head and neck carcinomas to identify lymph node metastasis:comparison with clinical and radiologi calexarninations[J].Head Neck,2003,25(4):280-288.
  • 7Niewiadomska H,Jeziorski A,O Borski B.The expression of thepro liferating antigen Ki67.PCNA and products of suppressorgene p53in primary invasive ductal breast carcinoma[J].J Exp Clin Cancer Res,1998,17(4):503-510.
  • 8Ozawa M,Ringwald M,Kemler R.Uvomorulin-catenin complex for mation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule[J].Proee Natl Acad Sci USA,1990,87(11):4246-4250.
  • 9Nakanishi Y,Ochiai A,Akimoto S,et al.Expression of E-cadherin alpharcatenin,beta-catenin and plakoglobin in esophageal earcinoma and its prognostic siguifience.Immunohistochemical analysis of 96 lesions[J].Oncology,1997,54(2):158-165.
  • 10Sorlie T,Perou CM,Tibshirani R,et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J].Proc Natl Acad Sci U S A,2001,98(19):10869-10874.

共引文献46

同被引文献17

  • 1Oike Y, Yasunaga K, Suda T. Angiopoietin-related/angiopoietinlike proteins regulate angiogenesis [J]. lnt J Hematol, 2004,80 ( 1 ) : 21- 28.
  • 2Ide S, Toiyama Y, Shimura T, et al. Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with E- sophageal Cancer [ J]. Ann Surg Onco1,2015,22(8) :2585-2592.
  • 3Gao L, Ge C, Fang T, et al. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma [J]. J Gastroenterol Hepatol, 2015,30 ( 2 ) : 396-404.
  • 4Shimura T, Toiyama Y, Tanaka K, et al. Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer E J 1. Anticancer Res ,2015,35 ( 9 ) :4633-4639.
  • 5Masuda T, Endo M, Yamamoto Y, et al. ANGPTL2 increases bone me- tastasis of breast cancer cells through enhancing CXCR4 signaling [ J]. Sci Rep,2015 ,5 :9170.
  • 6Endo M, Yamamoto Y, Nakano M, et al. Serum ANGPTL2 levels re- flect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis [ J ]. Int J Biol Markers,2014, 29 ( 3 ) : e239-e245.
  • 7Huang B, Cheng X, Wang D, et al. Adiponeetin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/ Sirtl/PGC-lalpha signaling [ J ]. Oncotarget, 2014, 5 ( 13 ) : 4732- 4745.
  • 8Gabfielson M, Bjorklund M, Carlson J, et al. Expression of mitochon- dfial regulators PGC-1 alpha and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma [ J 1. PLoS One, 2014,9(9) :e107109.
  • 9Wolf DA. Is reliance on mitochondrial respiration a " chink in the ar- mor " of therapy-resistant cancer [ J ]. Cancer Cell,2014,26 (6) :788- 795.
  • 10Ringelhan M, O' Connor T, Protzer U, et al. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets [ J ]. J Pathol, 2015,235 ( 2 ) : 355- 367.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部